Fibrinolytic Agents Concept

subject area of

• 14 Antithrombotic treatment of cerebrovascular disease  Academic Article
• 15 Side-effects of antithrombotic therapy  Academic Article
• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Academic Article
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Academic Article
• 6 Mechanism of action of the thrombolytic agents  Academic Article
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Academic Article
• A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats  Academic Article
• A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats  Academic Article
• A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke  Academic Article
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Academic Article
• A Patient-Focused Approach to Thrombolytic Use in the Management of Catheter Malfunction  Academic Article
• A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke  Academic Article
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Academic Article
• A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India.  Academic Article
• A guide to GRADE guidelines for the readers of JTH  Academic Article
• A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo  Academic Article
• A novel approach to thrombin inhibition  Academic Article
• A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)  Academic Article
• A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer  Academic Article
• A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.  Academic Article
• ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves  Academic Article
• Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis  Academic Article
• Acute coronary syndromes without ST segment elevation  Academic Article
• Acute stroke management.  Academic Article
• Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process  Academic Article
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Academic Article
• Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction  Academic Article
• Advances in Antithrombotic Therapy  Academic Article
• Advances in Antithrombotic Therapy: Novel Agents  Academic Article
• Advances in antithrombotic drug therapy for coronary artery disease  Academic Article
• After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy  Academic Article
• Altering Vessel Wall Fatty Acid Metabolism: A New Strategy for Antithrombotic Treatment  Academic Article
• American College of Chest Physicians Guidelines for Heparin-Induced Thrombocytopenia: Response  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy  Academic Article
• An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters  Academic Article
• An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials  Academic Article
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Academic Article
• Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial  Academic Article
• Anticoagulants in acute coronary syndromes  Academic Article
• Anticoagulation for prosthetic heart valves  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation therapy in patients with prosthetic heart valves.  Academic Article
• Antiphospholipid antibodies in critical illness  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antithrombin-Heparin Covalent Complex  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Drugs  Academic Article
• Antithrombotic Drugs  Academic Article
• Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation  Academic Article
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy Following Heart Valve Replacement  Academic Article
• Antithrombotic Therapy and Invasive Procedures  Academic Article
• Antithrombotic Therapy for Atrial Fibrillation  Academic Article
• Antithrombotic Therapy for Cerebrovascular Disorders  Academic Article
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antithrombotic Therapy for Peripheral Artery Disease  Academic Article
• Antithrombotic Therapy for Venous Thromboembolic Disease  Academic Article
• Antithrombotic Therapy in Children*  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Academic Article
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Academic Article
• Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry  Academic Article
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Academic Article
• Antithrombotic and Thrombolytic Therapy  Academic Article
• Antithrombotic and Thrombolytic Therapy: From Evidence to Application  Academic Article
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic drug development for atrial fibrillation: Proceedings, Washington, DC, July 25-27, 2005  Academic Article
• Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey  Academic Article
• Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events  Academic Article
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Academic Article
• Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends  Academic Article
• Antithrombotic therapy during pregnancy  Conference Paper
• Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report  Academic Article
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Academic Article
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Academic Article
• Antithrombotic therapy in aortic diseases: A narrative review  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy in children with venous thromboembolism  Academic Article
• Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic therapy: the expanding role of low molecular weight heparin.  Academic Article
• Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis  Academic Article
• Antithrombotic treatment for peripheral arterial disease  Academic Article
• Antithrombotics and anticoagulants in coronary syndromes and stroke.  Academic Article
• Apixaban for Extended Treatment of Venous Thromboembolism  Academic Article
• Apixaban in Patients with Atrial Fibrillation  Academic Article
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Academic Article
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Academic Article
• Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen  Academic Article
• Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy  Academic Article
• Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Are Asymptomatic DVTs Relevant?: Response  Academic Article
• Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.  Academic Article
• Assessment of antithrombotic drugs ex vivo and in vivo.  Academic Article
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Academic Article
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Academic Article
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Academic Article
• Beyond Heparin and Aspirin  Academic Article
• Beyond Unfractionated Heparin and Warfarin  Academic Article
• Biological basis and clinical implications of acetylsalicylic acid resistance  Academic Article
• Bivalirudin  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Academic Article
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Academic Article
• Bleeding associated with antithrombotic therapy.  Academic Article
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis  Academic Article
• Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.  Academic Article
• Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism  Academic Article
• Can we optimise treatment of thrombosis?  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian Consensus Conference on Coronary Thrombolysis--1994 update.  Academic Article
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Academic Article
• Catheter-Directed Thrombolysis for Pulmonary Embolism  Academic Article
• Central venous catheters: optimizing the suboptimal.  Academic Article
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial  Academic Article
• Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk  Academic Article
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Academic Article
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Academic Article
• Characterization of the Interactions of Plasminogen and Tissue and Vampire Bat Plasminogen Activators with Fibrinogen, Fibrin, and the Complex of d-Dimer Noncovalently Linked to Fragment E  Academic Article
• Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex  Academic Article
• Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism  Academic Article
• Choice of low molecular weight heparins  Academic Article
• Choice of low molecular weight heparins.  Academic Article
• Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents  Academic Article
• Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia  Academic Article
• Clinical potential of antithrombotic drugs in coronary syndromes  Academic Article
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Academic Article
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Academic Article
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conference Paper
• Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction)  Academic Article
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Academic Article
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Academic Article
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Academic Article
• Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study  Academic Article
• Consultative Hematology: The Pregnant Patient Pregnancy Loss  Academic Article
• Coronary thrombolysis--clinical guidelines and public policy: results of an Ontario practitioner survey.  Academic Article
• Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis  Academic Article
• Current use of biologicals in thrombosis and haemostasis  Academic Article
• DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE  Academic Article
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Academic Article
• Dabigatran-related coagulopathy: when can we assume the effect has “worn off”?  Academic Article
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients  Academic Article
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients  Academic Article
• Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective  Academic Article
• Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis  Academic Article
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Academic Article
• Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs  Academic Article
• Developing a novel antithrombotic in the academic environment  Academic Article
• Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation  Academic Article
• Diagnosis and Treatment of Venous Thromboembolism  Academic Article
• Diagnosis of DVT  Academic Article
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation  Academic Article
• Direct Thrombin Inhibitors in Cardiac Disease  Academic Article
• Direct thrombin inhibitors  Academic Article
• Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin  Conference Paper
• Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)?  Academic Article
• Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?  Academic Article
• Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation  Academic Article
• Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness  Academic Article
• Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events  Academic Article
• Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement  Academic Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Drug trials that have influenced our practice in the treatment of venous thromboembolism.  Academic Article
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Academic Article
• ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Academic Article
• Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect  Academic Article
• Effect of Aspirin on Hemostasis and Thrombosis  Academic Article
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Academic Article
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Academic Article
• Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients  Academic Article
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Academic Article
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Academic Article
• Effectiveness and safety of abciximab after failed thrombolytic therapy  Academic Article
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial  Academic Article
• Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.  Academic Article
• Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI)  Academic Article
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Academic Article
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Academic Article
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™  Academic Article
• Eicosanoids, Other Fatty Acid Metabolites and the Cardiovascular System: Are the Present Antithrombotic Approaches Rational?  Academic Article
• Emergence of the Primary Pediatric Stroke Center  Academic Article
• Endovascular Thrombectomy for Acute Ischemic Stroke  Academic Article
• Enhancement of the Activity of Optimum Concentrations of Urokinase by the Venom of Echis carinata  Academic Article
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Academic Article
• Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients  Academic Article
• Evidence-Based Management of Anticoagulant Therapy  Academic Article
• Evidence-based treatment of the antiphospholipid syndrome  Academic Article
• Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation  Academic Article
• Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.  Academic Article
• Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study  Academic Article
• Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials  Academic Article
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Academic Article
• External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)  Academic Article
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Academic Article
• Factors at Admission Associated With Bleeding Risk in Medical Patients  Academic Article
• Failure of Aspirin to Prevent Atherothrombosis  Academic Article
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Academic Article
• Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke  Academic Article
• Fibrinolytic Poly(dimethyl siloxane) Surfaces  Academic Article
• Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study  Academic Article
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery  Academic Article
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery  Academic Article
• Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery  Academic Article
• Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind Studies  Academic Article
• Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy  Academic Article
• Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial  Academic Article
• Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits  Academic Article
• GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE  Academic Article
• Getting intimate with the venous thrombus  Academic Article
• Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Guided Antithrombotic Therapy: Current Status and Future Research Direction  Academic Article
• Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines.  Academic Article
• Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary.  Academic Article
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Academic Article
• HEPARIN-INDUCED THROMBOCYTOPENIA: A Ten-Year Retrospective  Academic Article
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Academic Article
• Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.  Academic Article
• Heparan sulfate: Antithrombotic or not?  Academic Article
• Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate  Academic Article
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Academic Article
• Heparin and Low-Molecular-Weight Heparin  Academic Article
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Academic Article
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Academic Article
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Academic Article
• INHIBITION OF THROMBIN BY HIRUDIN GENETICALLY FUSED TO WILD-TYPE OR MUTANT ANTITHROMBIN  Academic Article
• Idiopathic gangrene in African children.  Academic Article
• Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada  Academic Article
• Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction  Academic Article
• In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence  Academic Article
• In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.  Academic Article
• In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome  Academic Article
• In vivo activity of a new heparinoid.  Academic Article
• In-Vitro Studies with Ancrod (‘Arvin’)  Academic Article
• Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children  Conference Paper
• Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st CenturyA Multinational Perspective  Academic Article
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Academic Article
• Inhibition of arterial thrombosis and platelet function by nafazatrom  Academic Article
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Academic Article
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Academic Article
• Initial Treatment of Venous Thromboembolism  Academic Article
• Initial treatment of venous thromboembolism.  Academic Article
• International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement  Academic Article
• International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2  Academic Article
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Academic Article
• Interventions that potentially limit myocardial infarct size: Overview of clinical trials  Academic Article
• Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis  Academic Article
• Intracranial Aneurysm Rupture Following Intravenous Thrombolysis for Stroke  Academic Article
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Academic Article
• Intracranial haemorrhage with bolus thrombolytic agents  Academic Article
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Academic Article
• Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question  Academic Article
• Left Atrial Appendage Occlusion Study (LAAOS): A randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention  Academic Article
• Left Atrial Appendage Occlusion Study II (LAAOS II)  Academic Article
• Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding  Academic Article
• Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Academic Article
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Academic Article
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Academic Article
• Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.  Academic Article
• Low anonymous voting compliance with the novel policy for managing conflicts of interest implemented in the 9th version of the American College of Chest Physicians antithrombotic guidelines  Academic Article
• Low molecular weight heparins in the treatment of unstable angina.  Academic Article
• Low rates of preventive practices in patients with peripheral vascular disease.  Academic Article
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Academic Article
• Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease  Academic Article
• Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis  Academic Article
• Lysine-derivatized polyurethane as a clot lysing surface: conversion of adsorbed plasminogen to plasmin and clot lysis in vitro  Academic Article
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Academic Article
• Management of a Patient with Catheter-Related Bloodstream Infection  Academic Article
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.  Academic Article
• Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage  Academic Article
• Management of thromboembolic disease in cancer patients.  Academic Article
• Management of unstable angina and myocardial infarction  Academic Article
• Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score  Academic Article
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Academic Article
• Medical device-induced thrombosis: what causes it and how can we prevent it?  Academic Article
• Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention  Academic Article
• Methodology for Antithrombotic and Thrombolytic Therapy Guideline Development  Academic Article
• Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy  Academic Article
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Mimicking the fibrinolytic system on material surfaces  Academic Article
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation  Academic Article
• Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction  Academic Article
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Academic Article
• Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism  Academic Article
• Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound1  Academic Article
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conference Paper
• New Anticoagulant Drugs  Academic Article
• New Anticoagulant Strategies  Academic Article
• New Antithrombotic Agents  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs: Potential for Use in Oncology  Academic Article
• New Antithrombotics  Academic Article
• New anticoagulants  Conference Paper
• New antithrombotic agents  Academic Article
• New antithrombotic agents—insights from clinical trials  Academic Article
• New oral anticoagulants in atrial fibrillation  Academic Article
• New-onset chest pain and palpitation  Academic Article
• Non-ST segment elevation acute coronary syndromes: A simplified risk-oriented algorithm  Academic Article
• Non-traumatic vascular emergencies: imaging and intervention in acute arterial conditions  Academic Article
• Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.  Academic Article
• Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.  Academic Article
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism  Academic Article
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Academic Article
• Optimization of Treatment for Venous Thromboembolism and Prevention of Recurrences  Academic Article
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Academic Article
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conference Paper
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Academic Article
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Academic Article
• Overview of the clinical results of pentasaccharide in major orthopedic surgery.  Academic Article
• PLATELET SUPPRESSIVE THERAPY  Academic Article
• PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.  Academic Article
• PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan  Academic Article
• Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study  Academic Article
• Parenteral Anticoagulants  Academic Article
• Part 5: Acute Coronary Syndromes  Academic Article
• Part 9: Acute Coronary Syndromes  Academic Article
• Part 9: Acute Coronary Syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations  Academic Article
• Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study  Academic Article
• Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke  Academic Article
• Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin  Academic Article
• Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Patterns of Stroke Transfers and Identification of Predictors for Thrombectomy  Academic Article
• Pediatric Stroke Initiatives and Preliminary Studies: What Is Known and What Is Needed?  Conference Paper
• Perioperative Aspirin for Prevention of Venous Thromboembolism  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative management of antithrombotic therapy.  Academic Article
• Perioperative management of antithrombotic therapy: lifting the fog  Academic Article
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Pharmacologic tools to reduce bleeding in surgery.  Academic Article
• Pharmacological Actions of Sulodexide  Academic Article
• Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis  Academic Article
• Plasmin accelerates platelet‐dependent prothrombinase formation without activating the platelets  Academic Article
• Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Academic Article
• Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma  Academic Article
• Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem  Academic Article
• Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial  Academic Article
• Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison  Academic Article
• Potential antidotes for reversal of old and new oral anticoagulants  Academic Article
• Practical Model-Based Dose Finding in Early-Phase Clinical Trials  Academic Article
• Pre Admission Antithrombotics are Associated with Improved Outcomes following Ischaemic Stroke: A Cohort from the Registry of the Canadian Stroke Network  Academic Article
• Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study  Academic Article
• Predicting tissue plasminogen activator use and success in in-center hemodialysis patients  Academic Article
• Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery  Academic Article
• Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.  Academic Article
• Prevention and treatment of venous thromboembolism during pregnancy  Academic Article
• Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator  Academic Article
• Prevention of Thrombus Growth by Antithrombin III-Dependent and Two Direct Thrombin Inhibitors in Rabbits: Implications for Antithrombotic Therapy  Academic Article
• Prevention of VTE in Orthopedic Surgery Patients  Academic Article
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Academic Article
• Prevention of thrombosis in antiphospholipid syndrome  Academic Article
• Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents  Academic Article
• Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)  Academic Article
• Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation  Academic Article
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.  Academic Article
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Academic Article
• Pros and cons of catheter lock solutions  Academic Article
• Protein-Resistant and Fibrinolytic Polyurethane Surfaces  Academic Article
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Academic Article
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Academic Article
• Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.  Academic Article
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Academic Article
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Academic Article
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Academic Article
• Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal  Academic Article
• Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty  Academic Article
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins  Academic Article
• Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines  Academic Article
• Regression Analysis with a Misclassified Covariate from a Current Status Observation Scheme  Academic Article
• Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery  Academic Article
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Academic Article
• Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors  Academic Article
• Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction  Academic Article
• Response to “Effect of Tissue Plasminogen Activator Dose and Interval on Stroke Severity”  Academic Article
• Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF  Academic Article
• Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin  Academic Article
• Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding  Academic Article
• Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry  Academic Article
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Academic Article
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Academic Article
• Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis  Academic Article
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Academic Article
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Academic Article
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Academic Article
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Academic Article
• Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion  Academic Article
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Academic Article
• Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction  Academic Article
• Routine heparin for patients with cancer? One answer, more questions  Academic Article
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Academic Article
• Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes  Academic Article
• Rules of evidence and clinical recommendations on the use of antithrombotic agents.  Academic Article
• STATIN DRUGS AND DIETARY ISOPRENOIDS AS ANTITHROMBOTIC AGENTS  Academic Article
• SUBOPTIMAL PREVENTIVE PRACTICES IN PATIENTS WITH CAROTID AND PERIPHERAL VASCULAR OCCLUSIVE DISEASE IN A TERTIARY REFERRAL SETTING  Academic Article
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Academic Article
• Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials  Academic Article
• Safety of thrombolysis in cerebral venous thrombosis  Academic Article
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Academic Article
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE  Academic Article
• Setting a standard for venous thromboembolism prophylaxis  Academic Article
• Sex differences in the antithrombotic effects of aspirin.  Academic Article
• Sex related differences in platelet function: the effect of aspirin.  Academic Article
• Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke  Academic Article
• Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation  Academic Article
• Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?  Academic Article
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Academic Article
• Significant association with location of central venous line placement and risk of venous thrombosis in children  Academic Article
• Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)  Academic Article
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group  Academic Article
• State of the Art-A Journey through the World of Antithrombotic Therapy  Academic Article
• State-of-the-Art-Review : Statins Induce Hypothrombotic States?  Academic Article
• Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)  Academic Article
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Academic Article
• Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST)  Academic Article
• Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program  Academic Article
• Studies on the medical treatment of deep vein thrombosis.  Academic Article
• Successors to heparin: new antithrombotic agents.  Academic Article
• Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach.  Academic Article
• Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points  Academic Article
• Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction  Academic Article
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Academic Article
• Systematic lower limb phlebography in acute spinal cord injury in 147 patients  Academic Article
• THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.  Academic Article
• THROMBOLYTIC THERAPY IN NEUROINTENSIVE CARE  Academic Article
• The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice  Academic Article
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Academic Article
• The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2  Academic Article
• The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro  Academic Article
• The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial  Academic Article
• The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer  Academic Article
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Academic Article
• The Perioperative Management of Antithrombotic Therapy  Academic Article
• The Primary and Secondary Prevention of Coronary Artery Disease  Academic Article
• The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model  Academic Article
• The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial  Academic Article
• The consensus report: is it ever the last word?  Academic Article
• The direct thrombin inhibitor hirudin  Academic Article
• The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial  Academic Article
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Academic Article
• The emerging role of low-molecular-weight heparin in cardiovascular medicine  Academic Article
• The evolving role of direct thrombin inhibitors in acute coronary syndromes.  Academic Article
• The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH  Academic Article
• The optimal antithrombotic dose of aspirin  Academic Article
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Academic Article
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.  Academic Article
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.  Academic Article
• The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality  Academic Article
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Academic Article
• The role of platelets and platelet inhibition in acute myocardial infarction  Academic Article
• The safety of antithrombotic therapy during pregnancy  Academic Article
• The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.  Academic Article
• The status of new anticoagulants  Academic Article
• The treatment of venous thromboembolism.  Academic Article
• The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study  Academic Article
• Theoretical and Practical Aspects of Thrombolytic Therapy  Academic Article
• Therapy of deep vein thrombosis.  Academic Article
• Thrombin and Antithrombotics  Academic Article
• Thrombin structure and function  Academic Article
• Thromboembolic Disease and Antithrombotic Therapy in Newborns  Academic Article
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism  Academic Article
• Thrombolysis Despite Recent Stroke  Academic Article
• Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.  Academic Article
• Thrombolysis in Pediatric Stroke Study  Academic Article
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Academic Article
• Thrombolytic Therapy  Academic Article
• Thrombolytic Therapy and Fatal Pulmonary Emboli  Academic Article
• Thrombolytic therapy for venous thromboembolism. Complications and contraindications.  Academic Article
• Thromboprophylaxis in medical–surgical critically ill patients  Academic Article
• Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial  Academic Article
• Thrombosis and anticoagulation.  Academic Article
• Thrombosis in Children  Academic Article
• Thrombosis.  Academic Article
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Academic Article
• Tissue Plasminogen Activator Overdose in Acute Ischemic Stroke Patients Linked to Poorer Functional Outcomes  Academic Article
• Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: The story of GISSI  Academic Article
• Transradial Approach for Coronary Angiography and Interventions  Academic Article
• Treating acute myocardial infarction.  Academic Article
• Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment for acute myocardial infarction: Overview of randomized clinical trials  Academic Article
• Treatment of Deep-Vein Thrombosis  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of acute ischemic stroke: from fibrinolysis to neurointervention  Academic Article
• Treatment with novel oral anticoagulants  Academic Article
• Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy  Academic Article
• Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents  Academic Article
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Academic Article
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Academic Article
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels  Academic Article
• Unstable Angina and Non–ST-Elevation Myocardial Infarction  Academic Article
• Unstable angina.  Academic Article
• Unstable angina.  Academic Article
• Update on heparin: what do we need to know?  Academic Article
• Updates in thrombosis in pediatrics: where are we after 20 years?  Academic Article
• Urgent Clinical Challenges in Children With Ischemic Stroke  Academic Article
• Urokinase Therapy: Dosage Schedules and Coagulant Side Effects  Academic Article
• Use of Antithrombotic Agents During Pregnancy  Academic Article
• Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study  Academic Article
• Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected].  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY  Academic Article
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Academic Article
• Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology-oncology specialists  Academic Article
• Vascular viewpoint  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Academic Article
• Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients  Academic Article
• Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease  Academic Article
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients  Academic Article
• Venous thromboembolism and bleeding in a community setting  Academic Article
• Venous thromboembolism in critical illness in a community intensive care unit  Academic Article
• Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review  Academic Article
• Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary?  Academic Article
• Vocal cord paralysis secondary to spontaneous internal carotid dissection: case report and systematic review of the literature  Academic Article
• What is the role for antithrombotics in cancer care?  Academic Article
• Which antithrombotic to use during PCI?  Academic Article
• Women’s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities  Academic Article
• XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.  Academic Article
• [Antithrombotic treatment of atrial fibrillation].  Academic Article